Hypertension, Vol 17, 480-484, Copyright © 1991 by American Heart Association
NE Rhaleb, N Rouissi, F Nantel, P D'Orleans-Juste and D Regoli
2-n-Butyl-4-chloro-5-hydroxy-methyl-1-[(2'-(1H)-tetrazol-5-yl)biph enyl- 4-
yl)methyl]imidazol potassium salt (DuP 753) is a nonpeptide angiotensin II
receptor antagonist that inhibits the contractile effects of angiotensin II
competitively and shows pA2 values of 8.27 on the rabbit aorta and jugular
vein, 8.66 on the rat portal vein and stomach, 8.19 on the rat urinary
bladder, and 8.36 on human colon, ileum, and urinary bladder. This agent
(more than 10(-5) M) exhibits no agonistic activity and does not affect the
contractile effects of norepinephrine, acetylcholine, bradykinin,
desArg9-bradykinin, substance P, neurokinin A, neurokinin B, or bombesin in
the various tissues. The present results demonstrate that DuP 753 is a
potent nonpeptide antagonist with high affinity, specificity, and
selectivity for the angiotensin receptor.
ARTICLES
DuP 753 is a specific antagonist for the angiotensin receptor
Department of Pharmacology, Medical School University of Sherbrooke, Quebec, Canada.
This article has been cited by other articles:
![]() |
Q. H. Chen and G. M. Toney Responses to GABA-A receptor blockade in the hypothalamic PVN are attenuated by local AT1 receptor antagonism Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1231 - R1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tagawa and R. A. L. Dampney AT1 Receptors Mediate Excitatory Inputs to Rostral Ventrolateral Medulla Pressor Neurons From Hypothalamus Hypertension, December 1, 1999; 34(6): 1301 - 1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Li, C. M. Ferrario, and K. B. Brosnihan J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1065 - 1070. [Abstract] [Full Text] |
||||
![]() |
D. G Kiely, R. I Cargill, N. M Wheeldon, W. J Coutie, and B. J Lipworth Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale Cardiovasc Res, January 1, 1997; 33(1): 201 - 208. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |